ClearPoint Neuro Inc.

CLPT | undefined

Price Alert Chart Builder DCF Calculator

At close: undefined

After-hours:

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

undefined%

(1Y)

Rating

Updated: Aug 29, 2026

40.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $-

1D Range

52W Range

Valuation (TTM)

PE -11.84

PB 38.88

EV/EBITDA -16.54

Valuation (NTM)

Forward PE N/A

Forward PEG 1.40

Price Target $23.50

Cash Flow

FCF Yield -7.5%

SBC Adj. FCF Yield -9.5%

SBC Impact -27.1%

Margins

Gross Margin 62.6%

Operating Margin -73.4%

FCF Margin -74.0%

Growth (CAGR)

Revenue 3Y | 5Y 24.9% | 23.6%

Dil EPS 3Y | 5Y -26.1% | -10.7%

FCF 3Y | 5Y -60.7% | -13.1%

Returns

ROA -39.9%

ROE -188.1%

ROIC -40.5%

Financial Health

Net Debt

$21.06M

Current Ratio 4.73

Interest Coverage -7.68

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minima...

Sector Healthcare

Industry Medical - Devices

Employees 172

IPO Date May 21, 2012

Website www.clearpointneuro.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$23.50

Upside

0.00%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞